股票价格上,导致公司的股价下跌. Beam insiders sold stock to pay taxes after strong earnings, causing shares to fall.

疗法内部人士,包括首席执行官约翰·埃文斯在内,2026年4月1日出售了大量股票,以支付从资产权奖项获得的税收义务. Beam Therapeutics insiders, including CEO John Evans, sold significant stock on April 1, 2026, to cover tax obligations from vested equity awards. 公司股价下跌至24.23美元. Following these sales, the company's stock fell to $24.23. Beam于2026年2月24日公布了强劲的季度盈利，每股收益为2.33美元，收入同比增长280%，但分析师预计今年将出现亏损。 Beam reported strong quarterly earnings on February 24, 2026, with $2.33 EPS and revenue up 280% year-over-year, though analysts project a loss for the current year.